Schroder Investment Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $221M | Sell |
1,585,507
-128,482
| -7% | -$18M | 0.18% | 109 |
|
|
2025
Q4 | $210M | Sell |
1,713,989
-329,007
| -16% | -$40M | 0.16% | 114 |
|
|
2025
Q3 | $230M | Sell |
2,042,996
-48,154
| -2% | -$5.47M | 0.18% | 107 |
|
|
2025
Q2 | $232M | Sell |
2,091,150
-63,753
| -3% | -$6.78M | 0.2% | 105 |
|
|
2025
Q1 | $241M | Sell |
2,154,903
-131,238
| -6% | -$13.5M | 0.24% | 92 |
|
|
2024
Q4 | $210M | Buy |
2,286,141
+282,787
| +14% | +$25.5M | 0.2% | 100 |
|
|
2024
Q3 | $168M | Buy |
2,003,354
+96,752
| +5% | +$7.38M | 0.17% | 121 |
|
|
2024
Q2 | $131M | Buy |
1,906,602
+322,362
| +20% | +$21.5M | 0.14% | 135 |
|
|
2024
Q1 | $116M | Sell |
1,584,240
-62,349
| -4% | -$4.79M | 0.14% | 137 |
|
|
2023
Q4 | $133M | Buy |
1,646,589
+132,679
| +9% | +$10.3M | 0.17% | 111 |
|
|
2023
Q3 | $113M | Buy |
1,513,910
+166,731
| +12% | +$12.8M | 0.17% | 121 |
|
|
2023
Q2 | $104M | Sell |
1,347,179
-198,968
| -13% | -$15.9M | 0.15% | 143 |
|
|
2023
Q1 | $128M | Sell |
1,546,147
-187,464
| -11% | -$15.5M | 0.19% | 108 |
|
|
2022
Q4 | $149M | Sell |
1,733,611
-62,391
| -3% | -$4.94M | 0.24% | 89 |
|
|
2022
Q3 | $111M | Sell |
1,796,002
-28,515
| -2% | -$1.8M | 0.18% | 121 |
|
|
2022
Q2 | $114M | Buy |
1,824,517
+887,812
| +95% | +$55M | 0.17% | 128 |
|
|
2022
Q1 | $55.9M | Buy |
936,705
+110,647
| +13% | +$7.07M | 0.07% | 267 |
|
|
2021
Q4 | $60M | Sell |
826,058
-46,256
| -5% | -$3.19M | 0.08% | 256 |
|
|
2021
Q3 | $60.9M | Sell |
872,314
-452,143
| -34% | -$31.8M | 0.09% | 227 |
|
|
2021
Q2 | $91.2M | Sell |
1,324,457
-370,982
| -22% | -$24.8M | 0.11% | 177 |
|
|
2021
Q1 | $110M | Sell |
1,695,439
-604,259
| -26% | -$39M | 0.14% | 136 |
|
|
2020
Q4 | $134M | Buy |
2,299,698
+194,874
| +9% | +$11.8M | 0.19% | 103 |
|
|
2020
Q3 | $131M | Buy |
2,104,824
+340,843
| +19% | +$23.6M | 0.21% | 96 |
|
|
2020
Q2 | $136M | Buy |
1,763,981
+83,780
| +5% | +$6.42M | 0.25% | 84 |
|
|
2020
Q1 | $131M | Sell |
1,680,201
-1,174,030
| -41% | -$81.1M | 0.28% | 73 |
|
|
2019
Q4 | $185M | Buy |
2,854,231
+761,583
| +36% | +$49.6M | 0.3% | 68 |
|
|
2019
Q3 | $132M | Sell |
2,092,648
-317,240
| -13% | -$20.7M | 0.23% | 96 |
|
|
2019
Q2 | $163M | Sell |
2,409,888
-352,393
| -13% | -$23.2M | 0.3% | 75 |
|
|
2019
Q1 | $180M | Sell |
2,762,281
-52,351
| -2% | -$3.48M | 0.32% | 68 |
|
|
2018
Q4 | $176K | Sell |
2,814,632
-518,710
| -16% | -$36.3M | 0.32% | 62 |
|
|
2018
Q3 | $257M | Buy |
3,333,342
+57,257
| +2% | +$4.32M | 0.44% | 48 |
|
|
2018
Q2 | $230M | Buy |
3,276,085
+415,334
| +15% | +$29.3M | 0.4% | 51 |
|
|
2018
Q1 | $216M | Sell |
2,860,751
-282,016
| -9% | -$22.4M | 0.37% | 59 |
|
|
2017
Q4 | $225M | Sell |
3,142,767
-496,650
| -14% | -$37.7M | 0.37% | 48 |
|
|
2017
Q3 | $294M | Sell |
3,639,417
-457,223
| -11% | -$35M | 0.51% | 32 |
|
|
2017
Q2 | $290M | Buy |
4,096,640
+464,576
| +13% | +$30.9M | 0.52% | 34 |
|
|
2017
Q1 | $245M | Buy |
3,632,064
+1,070,378
| +42% | +$75.3M | 0.44% | 40 |
|
|
2016
Q4 | $183M | Buy |
2,561,686
+47,170
| +2% | +$3.51M | 0.35% | 57 |
|
|
2016
Q3 | $199M | Sell |
2,514,516
-743,029
| -23% | -$60.4M | 0.37% | 55 |
|
|
2016
Q2 | $272M | Buy |
3,257,545
+173,379
| +6% | +$15.4M | 0.55% | 35 |
|
|
2016
Q1 | $284M | Buy |
3,084,166
+528,539
| +21% | +$47.7M | 0.59% | 32 |
|
|
2015
Q4 | $259M | Sell |
2,555,627
-97,078
| -4% | -$10.1M | 0.53% | 36 |
|
|
2015
Q3 | $260M | Buy |
2,652,705
+211,756
| +9% | +$23.5M | 0.55% | 35 |
|
|
2015
Q2 | $282M | Sell |
2,440,949
-696,287
| -22% | -$76.1M | 0.55% | 32 |
|
|
2015
Q1 | $317M | Buy |
3,137,236
+1,262,577
| +67% | +$128M | 0.62% | 27 |
|
|
2014
Q4 | $177M | Buy |
1,874,659
+99,320
| +6% | +$10.3M | 0.35% | 77 |
|
|
2014
Q3 | $189M | Buy |
1,775,339
+150,129
| +9% | +$14.7M | 0.25% | 81 |
|
|
2014
Q2 | $135M | Buy |
1,625,210
+733,232
| +82% | +$57.1M | 0.17% | 121 |
|
|
2014
Q1 | $63.2M | Buy |
891,978
+213,250
| +31% | +$16.7M | 0.07% | 223 |
|
|
2013
Q4 | $51M | Sell |
678,728
-1,943,828
| -74% | -$135M | 0.06% | 245 |
|
|
2013
Q3 | $165M | Sell |
2,622,556
-603,063
| -19% | -$36M | 0.4% | 58 |
|
|
2013
Q2 | $165M | Buy |
+3,225,619
| New | +$168M | 0.44% | 47 |
|
Other funds holding GILD
VCM
VPM
Schroder Investment Management Group's GILD Position: Q1 2026 in Review
Schroder Investment Management Group reduced its Gilead Sciences (GILD) stake by 7.5% in Q1 2026, selling an estimated $18M and leaving 1,585,507 shares worth $221M. The position accounts for 0.18% of the portfolio, ranked #109.
Schroder Investment Management Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $317M in Q1 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Schroder Investment Management Group held 1,585,507 shares of Gilead Sciences worth $221M as of Q1 2026.
- Schroder Investment Management Group sold 128,482 Gilead Sciences shares in Q1 2026, an estimated $18M.
- Gilead Sciences made up 0.18% of Schroder Investment Management Group's portfolio in Q1 2026, its #109 holding.
- Schroder Investment Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Schroder Investment Management Group's Gilead Sciences position peaked at $317M in Q1 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.